Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction

作者: M Chen , Y Zhang , V C Yu , Y-S Chong , T Yoshioka

DOI: 10.1038/CDD.2014.3

关键词: Programmed cell deathCellCancer cellAngiogenesisEndothelial stem cellCell biologyTransfectionApoptosisCell growthBiology

摘要: Isthmin (ISM) is a secreted 60-kDa protein that potently induces endothelial cell (EC) apoptosis. It suppresses tumor growth and angiogenesis in mice when stably overexpressed cancer cells. Although αvβ5 integrin serves as low-affinity receptor for ISM, the mechanism by which ISM mediates antiangiogenesis apoptosis ECs remain to be fully resolved. In this work, we report identification of cell-surface glucose-regulated 78 kDa (GRP78) high-affinity (Kd=8.6 nM). We demonstrated ISM-GRP78 interaction triggers not only activated but also cells expressing high level GRP78. Normal benign tend express low GRP78 are resistant ISM-induced Upon binding GRP78, internalized into through clathrin-dependent endocytosis essential its proapoptotic activity. Once inside cell, co-targets with mitochondria where it interacts ADP/ATP carriers on inner membrane blocks ATP transport from cytosol, thereby causing Hence, novel ligand targets trigger inducing mitochondrial dysfunction. The restricted high-level expression make them uniquely susceptible ISM-targeted Indeed, systemic delivery recombinant suppressed subcutaneous 4T1 breast carcinoma B16 melanoma eliciting selectively ECs. Together, work reveals pathway demonstrates potential cancer-specific dual-targeting anticancer agent.

参考文章(47)
J FOLKMAN, Role of angiogenesis in tumor growth and metastasis Seminars in Oncology. ,vol. 29, pp. 15- 18 ,(2002) , 10.1016/S0093-7754(02)70065-1
Kyle T Pfaffenbach, Amy S Lee, The critical role of GRP78 in physiologic and pathologic stress Current Opinion in Cell Biology. ,vol. 23, pp. 150- 156 ,(2011) , 10.1016/J.CEB.2010.09.007
Saran Kumar, Soheila Sharghi-Namini, Nithya Rao, Ruowen Ge, None, ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity. American Journal of Pathology. ,vol. 181, pp. 1056- 1068 ,(2012) , 10.1016/J.AJPATH.2012.05.022
C. Watts, W. Wickner, R. Zimmermann, M13 procoat and a pre-immunoglobulin share processing specificity but use different membrane receptor mechanisms. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 80, pp. 2809- 2813 ,(1983) , 10.1073/PNAS.80.10.2809
Lakshmi Chandrasekaran, Chao-Zhen He, Hebah Al-Barazi, Henry C. Krutzsch, M. Luisa Iruela-Arispe, David D. Roberts, Cell Contact–dependent Activation of α3β1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1 Molecular Biology of the Cell. ,vol. 11, pp. 2885- 2900 ,(2000) , 10.1091/MBC.11.9.2885
J. Stap, J. A. Aten, R. Van Driel, G. J. Brakenhoff, E. M. M. Manders, Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. Journal of Cell Science. ,vol. 103, pp. 857- 862 ,(1992) , 10.1242/JCS.103.3.857
Chunlei Wu, Camilo Orozco, Jason Boyer, Marc Leglise, James Goodale, Serge Batalov, Christopher L Hodge, James Haase, Jeff Janes, Jon W Huss, Andrew I Su, BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology. ,vol. 10, pp. 1- 8 ,(2009) , 10.1186/GB-2009-10-11-R130
Tong-Young Lee, Stefan Muschal, Elke A. Pravda, Judah Folkman, Amir Abdollahi, Kashi Javaherian, Angiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteins Blood. ,vol. 114, pp. 1987- 1998 ,(2009) , 10.1182/BLOOD-2008-12-197236
Ryan Lister, Joanne M. Hulett, Trevor Lithgow, James Whelan, Protein import into mitochondria: origins and functions today (review). Molecular Membrane Biology. ,vol. 22, pp. 87- 100 ,(2005) , 10.1080/09687860500041247
Yu Rebecca Miao, Bedrich L. Eckhardt, Yuan Cao, Renata Pasqualini, Pedram Argani, Wadih Arap, Robert G. Ramsay, Robin L. Anderson, Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78 Clinical Cancer Research. ,vol. 19, pp. 2107- 2116 ,(2013) , 10.1158/1078-0432.CCR-12-2991